Synthego, the leading provider of genome engineering products, and Eurofins Genomics, a global leader in bioanalytical t...
Singapore - Mylan N.V. announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide...
Eureka Therapeutics has announced publication in Cell Discovery validating its ARTEMIS antibody-TCR (AbTC...
Notable leadership change comes as Brickell prepares to progress its lead product candidate, sofpironium bromide, to Pha...
Researchers at the National Centre for Complementary and Integrative Health (NCCIH), part of the National Institutes of ...
Images from the world's first full-body 3D medical scanner named EXPLORER have been released. This scanner is developed ...
Danish dermatology specialists LEO Pharma and California based company PellePharm has announced a strategic development ...
The development of new medical products that are considered the highest priority for people in developing countries is h...
With the new parallel imaging method CAIPIRINHA, Mark Griswold, Peter Jakob and their colleagues have taken the technolo...
US based clinical-stage biotechnology company Magenta Therapeutics has announced that it has strengthened its executive ...
In order to scale up prevention and treatment, and increased investment, to protect vulnerable people from Malaria, WHO ...
LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will ass...
Sandoz, a Novartis division, and Pear Therapeutics, Inc., has announced the commercial launch of reSET for patients with...
Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...
Forbion, a leading European life science venture capital firm has announced that it has led a Series B financing round o...
The World Health Organization (WHO) is shifting its focus towards active screening of girls and women of childbearing ag...
Agilent Technologies Inc. has announced the opening of a new, purpose-built extension to its Little Island, Cork facilit...
Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes...
